Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IMRT in hypopharyngeal tumors.

Gabriela Studer1, Urs Martin Lütolf, Jacques Bernard Davis

  • 1Radiotherapie, USZ, Universitätsspital Zürich, Rämistrasse 100, 8091, Zürich, Switzerland. gabriela.studer@usz.ch

Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|May 17, 2006
PubMed
Summary

Intensity-modulated radiation therapy (IMRT) for hypopharyngeal cancer (HC) shows excellent early disease control and preserves larynx function. Lower SIB doses are advised for large tumors to prevent severe side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local Recurrence and Metastasis Define Distinct Recurrence Phenotypes in Soft Tissue Sarcoma.

Cancers·2026
Same author

Value operating system: a practical framework to measure outcomes-per-cost at the episode level.

BMJ open quality·2026
Same author

Twelve-Month Metastatic State as a Landmark-Based Prognostic Stratifier in Metastatic Sarcoma.

Cancers·2026
Same author

Locked-Window EQ-5D-5L (Index and VAS) Benchmarking in Sarcoma Care: Rule-Based Traffic-Light Classification Across Two Institutions.

Diseases (Basel, Switzerland)·2026
Same author

From Network Governance to Real-World-Time Learning: A High-Reliability Operating Model for Rare Cancers.

Cancers·2026
Same author

Organizing Care Matters: Fragmented Pathways Double Early Local Recurrence Risk in Sarcoma.

Cancers·2026

Area of Science:

  • Oncology
  • Radiation Oncology
  • Head and Neck Cancer

Background:

  • Data on Intensity-Modulated Radiation Therapy (IMRT) for hypopharyngeal cancer (HC) are limited.
  • Historical outcomes with conventional radiation techniques for HC are suboptimal.
  • This study evaluates early results of IMRT in a dedicated HC patient cohort.

Purpose of the Study:

  • To assess the efficacy and toxicity of Simultaneous Integrated Boost (SIB) IMRT in hypopharyngeal cancer patients.
  • To compare outcomes with historical data from conventional radiation techniques.
  • To evaluate patient-reported swallowing function and larynx preservation rates.

Main Methods:

  • 29 consecutive HC patients treated with SIB IMRT (60-71 Gy) between 2002-2005.
  • 86% received concurrent cisplatin-based chemotherapy.

Related Experiment Videos

  • Mean follow-up was 16 months; 60% had locally advanced disease (T3/4).

    • Main Results:

    • 2-year actuarial local, nodal, distant control, and overall survival rates were 90%, 93%, 93%, and 90%, respectively.
    • Larynx preservation was achieved in 25/26 definitively treated patients, with 23 experiencing no or minimal dysphagia (G0-1).
    • Two Grade 4 toxicities (laryngeal fibrosis, dysphagia) occurred with doses of 2.2 Gy/fraction.

    Conclusions:

    • SIB IMRT demonstrates excellent early disease control and high patient satisfaction with swallowing function in HC.
    • Larynx preservation rates are high with acceptable toxicity.
    • For large tumors involving laryngeal structures, SIB doses below 2.2 Gy/fraction are recommended to avoid Grade 4 reactions.